Search Results for: Biocancell

NASDAQ launch for biotech

Posted on February 2, 2019

I reported previously (see here) on Israel’s BioCanCell which is developing treatments for bladder, ovarian and pancreatic cancers. It has changed its name to Anchiano and plans to list on NASDAQ. In December, Anchiano began a pivotal trial of its … Continue reading →

Posted in Economy & Business | Leave a comment

Positive trials of bladder cancer treatment

Posted on September 28, 2014

Israel’s Biocancell Therapeutics has reported a successful clinical trial on high-risk bladder cancer patients.  It will allow the company to proceed to a Phase III trial of its BC-819 product, which is administered together with BCG, the standard treatment. http://www.globes.co.il/en/article-biocancell-share-jumps-on-positive-cancer-trial-results-1000974326

Posted in Israel's Medical Achievements | Leave a comment

Bladder cancer treatment success

Posted on March 24, 2013

Israel’s Biocancell Therapeutics Ltd has reported success in the Phase IIb clinical trial of BC-819 for the treatment of bladder cancer in patients for whom chemotherapy or standard treatment using Bacillus Calmette-Guerin (BCG) failed. http://www.globes.co.il/serveen/globes/docview.asp?did=1000830282

Posted in Israel's Medical Achievements | Leave a comment

Good results for ovarian cancer drug

Posted on March 18, 2012

Israel’s Biocancell Therapeutics announced that phase 1/II(a) trials have proved BC-819 to be safe and effective in treating ovarian cancer. http://www.globes.co.il/serveen/globes/docview.asp?did=1000733108&fid=1725

Posted in Israel's Medical Achievements | Leave a comment

Pancreatic cancer drug is fast-tracked

Posted on October 9, 2011

The US Food and Drugs Administration has given priority approval to new treatment BC819 from Israel’s Biocancell Therapeutics. http://www.globes.co.il/serveen/globes/docview.asp?did=1000687932&fid=1725

Posted in Israel's Medical Achievements | Leave a comment

Israel funds ‘wonder drug’ trial

Posted on August 14, 2011

Israel is giving 2.2 million shekels for trials by Israeli bio-tech Biocancell into the effectiveness of its BC-819 drug in treating pancreatic cancer. BC-819 may also treat other cancers. http://www.globes.co.il/serveen/globes/docview.asp?did=1000672742&fid=1725

Posted in Israel's Medical Achievements | Leave a comment